Applied Molecular Transp... Stock Price

-0.0064 (-0.65%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 121,401
Bid Price 0.771
Ask Price 1.30
News -
Day High 1.05


52 Week Range


Day Low 0.91
Company Name Stock Ticker Symbol Market Type
Applied Molecular Transport Inc AMTI NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0064 -0.65% 0.9732 00:00:05
Open Price Low Price High Price Close Price Prev Close
0.9311 0.91 1.05 0.9732 0.9796
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
724 121,401 $ 0.9869965 $ 119,822 - 0.8501 - 26.83
Last Trade Time Type Quantity Stock Price Currency
16:49:15 average 858 $ 0.9732 USD


Draw Mode:

Applied Molecular Transport Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 37.86M 38.90M 13.26M $ - $ - -2.67 -0.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - -9.96k 2.70%

more financials information »

Applied Molecular Transp... News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical AMTI Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.091.220.85011.00159,318-0.1168-10.72%
1 Month1.391.550.85011.19141,330-0.4168-29.99%
3 Months2.252.730.85011.83218,824-1.28-56.75%
6 Months7.468.000.85013.27334,738-6.49-86.95%
1 Year26.6426.830.85017.68317,315-25.67-96.35%
3 Years18.0678.220.850121.72266,712-17.09-94.61%
5 Years18.0678.220.850121.72266,712-17.09-94.61%

Applied Molecular Transp... Description

Applied Molecular Transport Inc is a clinical-stage biopharmaceutical company leveraging its proprietary technology platform to design and develop a pipeline of novel oral biologic product candidates to treat autoimmune, inflammatory, metabolic, and other diseases. Its proprietary technology platform allows it to exploit existing natural cellular trafficking pathways to facilitate the active transport of therapeutic payloads across the intestinal epithelium (IE) barrier. Its product candidate, AMT-101, is an oral IL-10 fusion protein that has been designed for active transport across the IE barrier into local GI tissue. IL-10 is a potent immunomodulatory cytokine that is known to be the master regulator of immune homeostasis, including within GI mucosal tissue.

Your Recent History
Applied Mo..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now